No. IN THE Supreme Court of the United States ———— MERCK & CO., INC., MERCK SHARP & DOHME CORP., AND IONIS PHARMACEUTICALS, INC., Petitioners, v. GILEAD SCIENCES, INC., Respondent. ———— On Petition for a Writ of Certiorari to the United States Court of Appeals for the Federal Circuit ———— PETITION FOR A WRIT OF CERTIORARI ———— BRUCE R. GENDERSON JEFFREY A. LAMKEN JESSAMYN S. BERNIKER Counsel of Record STANLEY E. FISHER MICHAEL G. PATTILLO, JR. JESSICA PALMER RYEN SARAH J. NEWMAN WILLIAMS & CONNOLLY LLP MOLOLAMKEN LLP 725 Twelfth Street, NW The Watergate, Suite 660 Washington, D.C. 20005 600 New Hampshire Ave., NW (202) 434-5000 Washington, D.C. 20037
[email protected] (202) 556-2000
[email protected] Counsel for Petitioners (Additional Counsel Listed on Inside Cover) :,/621(3(635,17,1*&2,1&± ±:$6+,1*721'& MICHELLE J. PARTHUM MOLOLAMKEN LLP 300 North LaSalle Street Chicago, IL 60654 (312) 450-6700
[email protected] QUESTION PRESENTED Whether the equitable defense of unclean hands pre- cludes legal relief in the form of damages. (i) ii PARTIES TO THE PROCEEDINGS BELOW Petitioners Merck & Co., Inc., Merck Sharp & Dohme Corp., and Isis Pharmaceuticals, Inc. (now known as Io- nis Pharmaceuticals, Inc.) were defendants/counter-claim- ants in the district court and appellants/cross-appellees in the court of appeals. Respondent Gilead Sciences, Inc., was plaintiff/ counter-defendant in the district court and appellee/ cross-appellant in the court of appeals. iii CORPORATE DISCLOSURE STATEMENT Pursuant to this Court’s Rule 29.6, petitioner Merck & Co., Inc., states that it has no parent corporation and that no publicly held company owns 10% or more of its stock.